AIFF
Firefly NeuroscienceยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About AIFF
Firefly Neuroscience, Inc.
A company that utilizes artificial intelligence technology to develop innovative neuroscience solutions
Information Technology Services
--
11/26/2021
NASDAQ Stock Exchange
13
12-31
Common stock
1100 Military Road, Kenmore, NY 14217
--
Firefly Neuroscience, Inc., and its wholly-owned subsidiary, Firefly Neuroscience Ltd., are engaged in the development, marketing and distribution of medical devices and technologies to enable high-resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain. Firefly Neuroscience Ltd., originally established in 2006 under the laws of the State of Israel and started operations as a development company, launched its US marketing and distribution activities in May 2014 through Elminda 2022 Inc.
Company Financials
EPS
AIFF has released its 2025 Q3 earnings. EPS was reported at -0.2, versus the expected 0, missing expectations. The chart below visualizes how AIFF has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
AIFF has released its 2025 Q3 earnings report, with revenue of 388.00K, reflecting a YoY change of 1075.76%, and net profit of -2.64M, showing a YoY change of 38.47%. The Sankey diagram below clearly presents AIFF's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
